Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients With Moderate-to-Severe Genital Psoriasis. J of Skin 2018, 2 (S1), S8. https://doi.org/10.25251/skin.2.supp.8.